Summary

Report Scope
The report provides an overview of the global peripheral blood mononuclear cells (PBMCs) market and analyzes market trends. It includes global revenue ($ Thousand) using 2025 as the base year, estimated data for 2026, and projected data for 2026 through 2031.
The report segments the market by product type, application, and technology. By product type, the market is segmented into cryopreserved or frozen PBMCs, peripheral blood mononuclear cell isolation and viability kits, cultured or fresh PBMCs, and others. Based on application, the market is categorized into oncology, immunology, vaccine development, toxicology, infectious disease, and others. By technology, the market is segmented into density gradient centrifugation, leukapheresis, and others. Geographical regions covered in this study include North America (the U.S., Canada, and Mexico), Europe (Germany, the U.K., Italy, France, Spain, and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia-Pacific), South America, and the Middle East and Africa (MEA) with a focus on the major countries in these regions.
The report focuses on the key drivers, trends, and challenges shaping the market and vendor landscape. It analyzes and discusses emerging technologies related to the market.
The report concludes with an analysis of the competitive landscape and highlights the leading global peripheral blood mononuclear cell companies. It also includes a dedicated section of company profiles covering company overviews, key financials, product portfolios, and recent developments.
Report Includes
- 40 data tables and 54 additional tables
- Examination of the global peripheral blood mononuclear cells (PBMCs) market, covering research applications, technological developments, and the growing role of immune cell analysis in life sciences and clinical research
- Market estimates based on 2025 data, with revenue forecasts and growth projections for the period from 2026 through 2031
- Analysis of market segments by product type, application, and isolation technique,
- Discussion of key market drivers, restraints, opportunities, and challenges influencing industry growth and adoption patterns
- Regional evaluation of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, including country-level analysis of major research and healthcare markets
- Competitive landscape assessment featuring company rankings, market share analysis, and strategic initiatives undertaken by leading market participants
- Profiles of established companies and emerging players involved in the PBMC market, highlighting their product offerings, business strategies, and recent developments
- Company profiles of major players within the industry, including BioIVT, CGT Global, Charles River Laboratories, Discovery Life Sciences, Lonza, and STEMCELL Technologies

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Technological Advances
Conclusion
Chapter 2 Market Overview
Overview
Source of PBMCs
Method of PBMC Isolation
Freezing and Thawing of PBMCs
Applications for PBMCs
Macroeconomic Factor Analysis
Healthcare and Life Sciences R&D Expenditure
Impact of the Israel-U.S. and Iran war
Porter’s Five Forces Analysis in the Peripheral Blood Mononuclear Cells Market
Potential for New Entrants (Moderate)
Bargaining Power of Suppliers (High)
Bargaining Power of Buyers (Moderate)
Threat of Substitutes (Moderate to High)
Competition in the Industry (High)
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Rising Immunology and Vaccine Research Demand
Growing Cell and Gene Therapy Development
Increasing Use of PBMCs in Biomarkers and Infectious Diseases
Market Restraints
High PBMC Processing and Storage Costs
Sample Variability and Viability Issues
Market Opportunities
Expansion of Precision Medicine and Biobanking
Emerging Markets
Market Challenges
Cold-Chain and Logistics Complexity
Ethical and Regulatory Concerns
Chapter 4 Regulatory Landscape
U.S.
Europe
Other Regions
Chapter 5 Emerging Technologies and Developments
Emerging Technologies
Automated PBMC Isolation Systems
Advanced Cryopreservation and DMSO-Free Technologies
Artificial Intelligence
Clinical Trials Analysis
Key Takeaways
Clinical Trials Analysis, by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase
Patent Analysis
Key Takeaways
Patents, by Year
By Top Applicant
By Top Owner
By Jurisdiction
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Cryopreserved or Frozen PBMC
Peripheral Blood Mononuclear Cell Isolation and Viability Kits
Cultured or Fresh PBMC
Others
Market Analysis by Technology
Key Takeaways
Density Gradient Centrifugation
Leukapheresis
Other Technologies
Market Analysis by Application
Key Takeaways
Oncology
Immunology
Infectious Disease
Vaccine Development
Toxicology
Other Applications
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
South America
Middle East and Africa (MEA)
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Leading Companies of the PBMC Market
Key Developments and Strategies
Chapter 8 Appendix
Methodology
Sources
Abbreviations
Company Profiles
AKADEUM LIFE SCIENCES
ATCC
BIOIVT
BIOLEGEND INC.
CGT GLOBAL
CHARLES RIVER LABORATORIES
CYTIVA
DISCOVERY LIFE SCIENCES
IXCELLS BIOTECHNOLOGIES
LONZA
MERCK KGAA
MILTENYI BIOTEC
PRECISION MEDICINE GROUP LLC
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
Emerging Start-ups/ Market Disruptors

ページTOPに戻る

List of Tables/Graphs

List of Tables
Summary Table : Global Market for Peripheral Blood Mononuclear Cells (PBMCs), by Region, Through 2031
Table 1 : Composition of Human PBMCs
Table 2 : Porter’s Five Forces Analysis: Overview
Table 3 : PBMC-Related Cost, 2026
Table 4 : Other Regions: PBMC Regulatory Landscape
Table 5 : Clinical Trials in PBMCs, by Type of Study, June 2026
Table 6 : Clinical Trials in PBMC, by Status, June 2026
Table 7 : Clinical Trials in PBMCs, by Phase, June 2026
Table 8 : Patents, by Top Applicant, 2023–2025
Table 9 : Patents, by Top Owner, 2023–2025
Table 10 : Patents, by Jurisdiction, 2023–2025
Table 11 : Global Market for PBMCs, by Product Type, Through 2031
Table 12 : Global Market for Cryopreserved or Frozen PBMCs, by Region, Through 2031
Table 13 : Major Manufacturers of PBMC Isolation and Viability Kits
Table 14 : Global Market for PBMC Isolation and Viability Kits, by Region, Through 2031
Table 15 : Global Market for Cultured or Fresh PBMC, by Region, Through 2031
Table 16 : Global Market for Other PBMC Products, by Region, Through 2031
Table 17 : Global Market for PBMC, by Technology, Through 2031
Table 18 : Global Market for Density Gradient Centrifugation of PBMCs, by Region,Through 2031
Table 19 : Global Market for Leukapheresis of PBMCs, by Region, Through 2031
Table 20 : Global Market for Other Technologies of PBMCs, by Region, Through 2031
Table 21 : Global Market for PBMCs, by Application, Through 2031
Table 22 : Global Market for Oncology Applications of PBMCs, by Region, Through 2031
Table 23 : Global Market for Immunology Applications of PBMCs, by Region, Through 2031
Table 24 : Global Market for Infectious Disease Applications of PBMCs, by Region,Through 2031
Table 25 : Global Market for Vaccine Development Applications of PBMCs, by Region, Through 2031
Table 26 : Global Market for Toxicology Applications of PBMCs, by Region, Through 2031
Table 27 : Global Market for Other Applications of PBMCs, by Region, Through 2031
Table 28 : Global Market for PBMCs, by Region, Through 2031
Table 29 : North American Market for PBMCs, by Country, Through 2031
Table 30 : North American Market for PBMCs, by Product Type, Through 2031
Table 31 : North American Market for PBMCs, by Technology, Through 2031
Table 32 : North American Market for PBMCs, by Application, Through 2031
Table 33 : European Market for PBMCs, by Country, Through 2031
Table 34 : European Market for PBMCs, by Product Type, Through 2031
Table 35 : European Market for PBMCs, by Technology, Through 2031
Table 36 : European Market for PBMCs, by Application, Through 2031
Table 37 : Asia-Pacific Market for PBMCs, by Country, Through 2031
Table 38 : Asia-Pacific Market for PBMCs, by Product Type, Through 2031
Table 39 : Asia-Pacific Market for PBMCs, by Technology, Through 2031
Table 40 : Asia-Pacific Market for PBMCs, by Application, Through 2031
Table 41 : South American Market for PBMCs, by Product Type, Through 2031
Table 42 : South American Market for PBMCs, by Technology, Through 2031
Table 43 : South American Market for PBMCs, by Application, Through 2031
Table 44 : MEA Market for PBMCs, by Product Type, Through 2031
Table 45 : MEA Market for PBMCs, by Technology, Through 2031
Table 46 : MEA Market for PBMCs, by Application, Through 2031
Table 47 : Competitive Analysis of the Global PBMCs Market, 2025
Table 48 : PBMC Market: Recent Strategic Developments, 2024–2026
Table 49 : Report Information Sources
Table 50 : Abbreviations Used in the PBMCs Market Report
Table 51 : Akadeum Life Sciences: Company Snapshot
Table 52 : Akadeum Life Sciences: Product Portfolio
Table 53 : Akadeum Life Sciences: News/Key Developments, 2025-2026
Table 54 : ATCC: Company Snapshot
Table 55 : ATCC: Product Portfolio
Table 56 : ATCC: News/Key Development, 2024
Table 57 : BioIVT: Company Snapshot
Table 58 : BioIVT: Product Portfolio
Table 59 : BioIVT: News/Key Development, 2024
Table 60 : BioLegend Inc.: Company Snapshot
Table 61 : BioLegend Inc.: Product Portfolio
Table 62 : CGT Global: Company Snapshot
Table 63 : CGT Global: Product Portfolio
Table 64 : Charles River Laboratories: Company Snapshot
Table 65 : Charles River Laboratories: Financial Performance, FY 2024 and 2025
Table 66 : Charles River Laboratories: Product Portfolio
Table 67 : Cytiva: Company Snapshot
Table 68 : Cytiva: Product Portfolio
Table 69 : Discovery Life Sciences: Company Snapshot
Table 70 : Discovery Life Sciences: Product Portfolio
Table 71 : Discovery Life Sciences: News/Key Development, 2024
Table 72 : iXCells Biotechnologies: Company Snapshot
Table 73 : iXCells Biotechnologies: Product Portfolio
Table 74 : iXCells Biotechnologies: News/Key Development, 2026
Table 75 : Lonza: Company Snapshot
Table 76 : Lonza: Financial Performance, FY 2024 and 2025
Table 77 : Lonza: Product Portfolio
Table 78 : Merck KGaA: Company Snapshot
Table 79 : Merck KGaA: Financial Performance, FY 2024 and 2025
Table 80 : Merck KGaA: Product Portfolio
Table 81 : Miltenyi Biotec: Company Snapshot
Table 82 : Miltenyi Biotec: Product Portfolio
Table 83 : Miltenyi Biotec: News/Key Development, 2024
Table 84 : Precision Medicine Group LLC: Company Snapshot
Table 85 : Precision Medicine Group LLC: Product Portfolio
Table 86 : Precision Medicine Group LLC: News/Key Development, 2026
Table 87 : STEMCELL Technologies: Company Snapshot
Table 88 : STEMCELL Technologies: Product Portfolio
Table 89 : STEMCELL Technologies: News/Key Development, 2025
Table 90 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 91 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
Table 92 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 93 : List of Few Emerging Start-ups/ Market Disruptors

List of Figures
Summary Figure : Global Market Shares of Peripheral Blood Mononuclear Cells (PBMCs), by Region, 2025
Figure 1 : Porter’s Five Forces Analysis of the PBMC Market
Figure 2 : Market Dynamics of PBMC
Figure 3 : Emerging Trends/Technologies in the PBMC Market
Figure 4 : Patents Granted, by Year, 2023–2025
Figure 5 : Global Market Shares of PBMCs, by Product Type, 2025
Figure 6 : Global Market Shares of PBMC, by Technology, 2025
Figure 7 : Global Market Shares of PBMCs, by Application, 2025
Figure 8 : Global Market Shares of PBMCs, by Region, 2025
Figure 9 : North American Market Shares of PBMCs, by Country, 2025
Figure 10 : European Market Shares of PBMCs, by Country, 2025
Figure 11 : Asia-Pacific Market Shares of PBMCs, by Country, 2025
Figure 12 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2025
Figure 13 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2025
Figure 14 : LONZA: Revenue Shares, by Business Unit, FY 2025
Figure 15 : LONZA: Revenue Shares, by Country/Region, FY 2025
Figure 16 : Merck KGaA: Revenue Shares, by Business Unit, FY 2025
Figure 17 : Merck KGaA: Revenue Shares, by Country/Region, FY 2025
Figure 18 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
Figure 19 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025